13F Portfolios

Jones Hill Capital LP: ANI PHARMACEUTICALS INC (ANIP): Quarterly 13F Position History

As of Q2 2026, Jones Hill Capital LP reported 233,808 shares of ANI PHARMACEUTICALS INC (ANIP), worth $19.4M and representing 4.1% of its 13F equity book. Quarter-over-quarter share count change: 84,783 (-26.6%) . The position first appeared in Q1 2026 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.

Recent initiation: Jones Hill Capital LP first reported ANIP on the Q1 2026 filing, so fewer than three quarters of history are available.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q2 2026 233,808 84,783 -26.6% $19.4M 4.1% $82.8
Q1 2026 318,591 $24.5M 5.3% $76.9

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.

When did Jones Hill Capital LP first disclose a ANIP position in 13F-HR filings?

Jones Hill Capital LP first reported ANI PHARMACEUTICALS INC (ANIP) on its 13F-HR filing for the period ending 2026-03-31 (Q1 2026). The position has appeared on 2 reported quarters within Pactolio's tracked window.

What was Jones Hill Capital LP's most recent quarter-over-quarter share-count change in ANIP?

Between Q1 2026 and Q2 2026, Jones Hill Capital LP reduced its ANIP position by 84,783 shares (-26.6%), leaving 233,808 shares at a market value of $19.4M.

Does the implied price-per-share represent Jones Hill Capital LP's cost basis in ANIP?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.